{"id":579582,"date":"2026-02-24T08:50:26","date_gmt":"2026-02-24T08:50:26","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/?p=574157"},"modified":"2026-04-23T11:53:59","modified_gmt":"2026-04-23T11:53:59","slug":"navigating-fda-complete-response-letters-clarivate","status":"publish","type":"post","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/ko\/blog\/navigating-fda-complete-response-letters-clarivate\/","title":{"rendered":"\uc644\uc804\uc751\ub2f5\uc11c\ud55c(CRL) \ub300\uc751 \uc804\ub7b5: \ud074\ub798\ub9ac\ubca0\uc774\ud2b8 \uc194\ub8e8\uc158\uc774 \uc81c\uc57d\uc0ac\uc758 \uc2b9\uc778 \uacbd\ub85c \uc124\uacc4\ub97c \ub3d5\ub294 \ubc29\ubc95"},"content":{"rendered":"

\uc57d\ubb3c\uc758 \uc2dc\uc7a5 \uc9c4\uc785 \uacbd\ub85c\uac00 \uc608\uc0c1\uce58 \ubabb\ud55c \uaddc\uc81c \uc870\uce58\ub85c \ubcf5\uc7a1\ud574\uc9c8 \uacbd\uc6b0, \uc81c\uc57d\uc0ac\ub294 \uc911\ub300\ud55c \uac08\ub9bc\uae38\uc5d0 \ub193\uc774\uac8c \ub429\ub2c8\ub2e4. \uc2e0\uc18d\ud558\uace0 \ud6a8\uacfc\uc801\uc73c\ub85c \ub300\uc751\ud558\uc9c0 \ubabb\ud558\uba74 \uac1c\ubc1c \uc77c\uc815\uc740 \ubb3c\ub860 \uacbd\uc7c1 \uc6b0\uc704\uae4c\uc9c0 \uc783\uc744 \uc218 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \ud074\ub798\ub9ac\ubca0\uc774\ud2b8\uc758 \u20182026\ub144 \ube14\ub85d\ubc84\uc2a4\ud130 \uc2e0\uc57d’<\/a>\ubcf4\uace0\uc11c\uc5d0\uc11c \uc8fc\ubaa9\ud55c \uce58\ub8cc\uc81c \uc911\u00a0 Sanofi\uc758 tolebrutinib\uacfc Corcept Therapeutics\uc758 relacorilant\ub3c4 2025\ub144 \ub9d0 \uc774\ub7ec\ud55c \ub09c\uad00\uc5d0 \uc9c1\uba74\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n

FDA\ub294 2025\ub144 12\uc6d4 23\uc77c \ube44\uc7ac\ubc1c\uc131 \uc774\ucc28\uc9c4\ud589\uc131 \ub2e4\ubc1c\uc131\uacbd\ud654\uc99d(nrSP-MS) \uce58\ub8cc\uc81c tolebrutinib<\/a>\uc5d0 \ub300\ud574, \uadf8\ub9ac\uace0 2025\ub144 12\uc6d4 30\uc77c \ucfe0\uc2f1\uc99d\ud6c4\uad70 \uce58\ub8cc\uc81c relacorilant<\/a>\uc5d0 \ub300\ud574 \uac01\uac01 \uc644\uc804\uc751\ub2f5\uc11c\ud55c(CRL, Complete Response Letter)\uc744 \ubc1c\ud589\ud588\uc2b5\ub2c8\ub2e4. \uc774 \uacb0\uc815\uc740 \ub9ce\uc740 \uc5c5\uacc4 \uad00\uacc4\uc790\ub4e4\uc5d0\uac8c\ub294 \uc608\uc0c1\ubc16\uc758 \uc77c\uc774\uc5c8\uc2b5\ub2c8\ub2e4. tolebrutinib\uc740 \uc6b0\uc120\uc2ec\uc0ac(Priority Review)\uc640 \ud601\uc2e0\uce58\ub8cc\uc81c \uc9c0\uc815(Breakthrough Therapy designation)\uc744 \ubaa8\ub450 \ubc1b\uc740 \uc0c1\ud0dc\uc600\uace0, relacorilant\ub294 \ud575\uc2ec \uc784\uc0c1\uc2dc\ud5d8\uc778 GRACE\uc5d0\uc11c 1\ucc28 \ud3c9\uac00\ubcc0\uc218\ub97c \ucda9\uc871\ud588\uc744 \ubfd0 \uc544\ub2c8\ub77c GRADIENT \uc2dc\ud5d8\uc5d0\uc11c\ub3c4 \uc774\ub97c \ub4b7\ubc1b\uce68\ud558\ub294 \ud655\uc99d \ub370\uc774\ud130\ub97c \ud655\ubcf4\ud588\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4.<\/p>\n

<\/h3>\n

\uc644\uc804\uc751\ub2f5\uc11c\ud55c(CRL)\uc774\ub780?<\/strong><\/h3>\n

\uc644\uc804\uc751\ub2f5\uc11c\ud55c(CRL, Complete Response Letter)\uc740 FDA\uac00 \uae30\uc874\uc758 \u2018\uc2b9\uc778 \uac00\ub2a5(approvable)\u2019 \ubc0f \u2018\uc2b9\uc778 \ubd88\uac00(not approvable)\u2019 \uc11c\ud55c\uc744 \ub300\uccb4\ud558\uae30 \uc704\ud574 2008\ub144\uc5d0 \ub3c4\uc785\ud55c \uc81c\ub3c4\uc785\ub2c8\ub2e4. \uc774\ub294 \uc81c\ucd9c\ub41c \uc2e0\uccad\uc11c\uac00 \ud604\uc7ac \uc0c1\ud0dc\ub85c\ub294 \uc2b9\uc778\ub420 \uc218 \uc5c6\uc74c\uc744 \uc911\ub9bd\uc801\uc778 \ubc29\uc2dd\uc73c\ub85c \uc804\ub2ec\ud558\uae30 \uc704\ud574 \ub9c8\ub828\ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uacf5\uc2dd\uc801\uc73c\ub85c\ub294 \uc911\ub9bd\uc801\uc778 \ud615\uc2dd\uc744 \ucde8\ud558\uace0 \uc788\uc9c0\ub9cc, CRL\uc740 \uc2e4\uc81c\ub85c \ub9e4\uc6b0 \uc911\uc694\ud55c \uc758\ubbf8\ub97c \uac16\uc2b5\ub2c8\ub2e4. FDA\uac00 \ud655\uc778\ud55c \uad6c\uccb4\uc801\uc778 \ubcf4\uc644 \uc0ac\ud56d\uc744 \uc0c1\uc138\ud788 \uc81c\uc2dc\ud558\uba70, \uc774\ub97c \ud574\uacb0\ud558\uae30 \uc704\ud55c \ub2e4\uc74c \ub2e8\uacc4\ub3c4 \uc77c\ubc18\uc801\uc73c\ub85c \ud568\uaed8 \uc548\ub0b4\ud558\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. CRL\uc774 \ubc1c\ud589\ub418\ub294 \ub300\ud45c\uc801\uc778 \uc0ac\uc720\ub85c\ub294 \ucd94\uac00 \ub370\uc774\ud130\uac00 \ud544\uc694\ud55c \uc548\uc804\uc131 \ub610\ub294 \uc720\ud6a8\uc131 \uc6b0\ub824, \uc81c\uc870 \ub610\ub294 \ud488\uc9c8\uad00\ub9ac\uc0c1\uc758 \ubbf8\ube44, \ubd88\ucda9\ubd84\ud55c \uc704\ud5d8\uad00\ub9ac \uc804\ub7b5, \uadf8\ub9ac\uace0 \ud3b8\uc775-\uc704\ud5d8 \ud3c9\uac00\ub97c \ub4b7\ubc1b\uce68\ud558\uae30\uc5d0 \ubd80\uc871\ud55c \uadfc\uac70 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n

CRL\uc740 \uac70\uc808\uc774 \uc544\ub2c8\ub77c \uc77c\uc2dc\uc801 \ub09c\uad00\uc785\ub2c8\ub2e4<\/strong><\/p>\n

CRL\uc740 \ubd84\uba85 \uac1c\ubc1c \uacfc\uc815\uc5d0\uc11c\uc758 \ub09c\uad00\uc774\uc9c0\ub9cc, \uadf8\ub807\ub2e4\uace0 \uace7\ubc14\ub85c \uac70\uc808\uc744 \uc758\ubbf8\ud558\ub294 \uac83\uc740 \uc544\ub2d9\ub2c8\ub2e4. \uc804\uccb4 \uc2e0\uccad\uc11c \uac00\uc6b4\ub370 \uc57d 41%\uac00 CRL\uc744 \ubc1b\uc73c\uba70<\/a>, \uadf8\uc911 \uc808\ubc18 \uc774\uc0c1\uc740 \uacb0\uad6d \uc2b9\uc778\uc744 \ud68d\ub4dd\ud569\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uacb0\uc815\uc774 \ub0b4\ub824\uc9c4 \ubc30\uacbd\uacfc \uc774\ud6c4 \uc5b4\ub5a4 \uc808\ucc28\uac00 \uc774\uc5b4\uc9c0\ub294\uc9c0\ub97c \uc774\ud574\ud558\ub294 \uac83\uc740, \uaddc\uc81c \uc694\uac74\uc5d0 \ub300\uc751\ud574\uc57c \ud558\ub294 \uac1c\ubc1c\uc0ac\uc5d0 \uc911\uc694\ud55c \uc2dc\uc0ac\uc810\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n

Sanofi\uc640 Corcept Therapeutics\uc5ed\uc2dc \uc55e\uc73c\ub85c\uc758 \ub300\uc751 \uacfc\uc815\uc5d0\uc11c \uc815\uad50\ud55c \uc778\ud154\ub9ac\uc804\uc2a4, \uc120\ub840 \ubd84\uc11d, \uc804\ub7b5\uc801\uc778 \uadfc\uac70 \ub9c8\ub828\uc774 \ud544\uc694\ud569\ub2c8\ub2e4. \ud074\ub798\ub9ac\ubca0\uc774\ud2b8\uc758 \ud1b5\ud569\ud615 AI \uae30\ubc18 \uc194\ub8e8\uc158\uc740 \uaddc\uc81c \uc758\uc0ac\uacb0\uc815\uc744 \uc9c0\uc6d0\ud558\uace0, \uc7ac\uc81c\ucd9c \uc804\ub7b5\uc744 \uac15\ud654\ud558\uba70, \uad81\uadf9\uc801\uc73c\ub85c \uce58\ub8cc\uc81c\uac00 \ud658\uc790\uc5d0\uac8c \ub354 \ube68\ub9ac \ub3c4\ub2ec\ud560 \uc218 \uc788\ub3c4\ub85d \ub3d5\uae30 \uc704\ud574 \uc124\uacc4\ub418\uc5c8\uc2b5\ub2c8\ub2e4.<\/p>\n

<\/h3>\n

\uc0c1\uc774\ud55c \uaddc\uc81c \uacfc\uc81c\uc5d0\ub294 \ub9de\ucda4\ud615 \uc804\ub7b5\uc774 \ud544\uc694\ud569\ub2c8\ub2e4.<\/strong><\/h3>\n

\uad6c\uccb4\uc801\uc778 \ud574\uacb0 \ubc29\uc548\uc744 \uc0b4\ud3b4\ubcf4\uae30\uc5d0 \uc55e\uc11c, Sanofi\uc640 Corcept Therapeutics\uac00 \uc9c1\uba74\ud55c CRL\uc758 \uc131\uaca9\uc774 \uadfc\ubcf8\uc801\uc73c\ub85c \ub2e4\ub974\uba70, \uc774\uc5d0 \ub530\ub77c \uac01\uac01\uc5d0 \ub9de\ub294 \uc804\ub7b5\uc774 \ud544\uc694\ud558\ub2e4\ub294 \uc810\uc744 \uc774\ud574\ud558\ub294 \uac83\uc774 \uc911\uc694\ud569\ub2c8\ub2e4.<\/p>\n

Sanofi\uc758 tolebrutinib<\/strong>\uc740 \uc911\uc99d \uc57d\ubb3c \uc720\ubc1c \uac04\uc190\uc0c1(DILI) \uc704\ud5d8\uc744 \uc911\uc2ec\uc73c\ub85c \ud55c \uc548\uc804\uc131 \uc774\uc288 \uae30\ubc18 CRL<\/strong>\uc5d0 \uc9c1\uba74\ud574 \uc788\uc2b5\ub2c8\ub2e4. FDA\ub294 \ud574\ub2f9 \uc704\ud5d8\uc744 \u201c\uc911\ub300\ud558\uace0 \uc774\ub840\uc801\uc73c\ub85c \ub192\uc740 \uc218\uc900\u201d\uc73c\ub85c \ud3c9\uac00\ud588\uc73c\uba70, \u201c\uba85\ud655\ud55c \ud3b8\uc775\uc774 \uc785\uc99d\ub418\uace0 \uadf8 \ud3b8\uc775\uc774 \uc911\uc99d DILI \uc704\ud5d8\uc744 \uc0c1\ud68c\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\ub294 \ud658\uc790\uad70\uc744 \ud655\uc778\ud560 \uc218 \uc5c6\uc5c8\ub2e4\u201d\uace0 \uacb0\ub860\uc9c0\uc5c8\uc2b5\ub2c8\ub2e4. \uc774\uc5d0 \ub530\ub77c Sanofi\ub294 \ubcf4\ub2e4 \uac15\ud654\ub41c \uc704\ud5d8 \uc644\ud654 \uc804\ub7b5\uc744 \uc81c\uc2dc\ud558\uac70\ub098, \uc704\ud5d8\uc774 \ub0ae\uc740 \ud658\uc790 \ud558\uc704\uad70\uc744 \uc2dd\ubcc4\ud558\uac70\ub098, \ucd94\uac00\uc801\uc778 \uc548\uc804\uc131 \uadfc\uac70\ub97c \ud655\ubcf4\ud574\uc57c \ud558\ub294 \uacfc\uc81c\ub97c \uc548\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n

\ud55c\ud3b8, Corcept Therapeutics\uc758 relacorilant<\/strong>\ub294 \uadfc\uac70 \ucda9\ubd84\uc131(evidence adequacy) \uad00\ub828 CRL<\/strong>\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4. FDA\ub294 GRACE \uc784\uc0c1\uc2dc\ud5d8\uc774 1\ucc28 \ud3c9\uac00\ubcc0\uc218\ub97c \ucda9\uc871\ud588\uc74c\uc744 \uc778\uc815\ud558\uba74\uc11c\ub3c4, \u201c\ucd94\uac00\uc801\uc778 \uc720\ud6a8\uc131 \uadfc\uac70 \uc5c6\uc774\ub294 relacorilant\uc5d0 \ub300\ud574 \uae0d\uc815\uc801\uc778 \ud3b8\uc775-\uc704\ud5d8 \ud3c9\uac00\uc5d0 \ub3c4\ub2ec\ud560 \uc218 \uc5c6\ub2e4\u201d\uace0 \ubc1d\ud614\uc2b5\ub2c8\ub2e4. \uc774\ub294 \ub2e4\uc591\ud55c \ud658\uc790 \ud2b9\uc131\uc744 \ubcf4\uc774\ub294 \ucfe0\uc2f1\uc99d\ud6c4\uad70 \uc9d1\ub2e8 \uc804\ubc18\uc5d0\uc11c, \uc784\uc0c1\uc801 \uc720\uc758\uc131\uacfc \ud3b8\uc775-\uc704\ud5d8 \uade0\ud615\uc744 \ubcf4\ub2e4 \ud3ec\uad04\uc801\uc73c\ub85c \uc785\uc99d\ud560 \ud544\uc694\uac00 \uc788\uc74c\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4.<\/p>\n

 <\/p>\n

\ud074\ub798\ub9ac\ubca0\uc774\ud2b8 \ud1b5\ud569 \uc778\ud154\ub9ac\uc804\uc2a4 \ud50c\ub7ab\ud3fc\uc774 CRL \ub300\uc751\uc744 \uc9c0\uc6d0\ud558\ub294 \ubc29\uc2dd <\/strong><\/h3>\n

\ud074\ub798\ub9ac\ubca0\uc774\ud2b8\uc758 \ud1b5\ud569 \ub370\uc774\ud130 \ud50c\ub7ab\ud3fc\uacfc AI \uae30\ubc18 \uc194\ub8e8\uc158\uc740 \uc0dd\uba85\uacfc\ud559 \uae30\uc5c5\uc5d0 \uc778\ud154\ub9ac\uc804\uc2a4, \ubd84\uc11d \uc5ed\ub7c9, \uadf8\ub9ac\uace0 \uc804\ub7b5\uc801 \uc778\uc0ac\uc774\ud2b8\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc774\ub7ec\ud55c AI \uae30\ubc18 \uc811\uadfc \ubc29\uc2dd\uc740 \uc2e0\uc57d \uac1c\ubc1c \ubc0f \uc0c1\uc5c5\ud654 \uc804\ubc18\uc5d0 \uac78\uccd0 \uc9c8\ubb38\uc5d0\uc11c \uc778\uc0ac\uc774\ud2b8 \ub3c4\ucd9c\uae4c\uc9c0 \uac78\ub9ac\ub294 \uc2dc\uac04\uc744 \ud68d\uae30\uc801\uc73c\ub85c \ub2e8\ucd95\uc2dc\ud0a4\uba70, \uacfc\uac70\uc5d0\ub294 \uc218\uc8fc\uc5d0 \uac78\uccd0 \uc218\uc791\uc5c5 \ubd84\uc11d\uc774 \ud544\uc694\ud588\ub358 \uacfc\uc815\uc744 \uc774\uc81c\ub294 \uba87 \uc2dc\uac04 \ub0b4\uc5d0 \uc2e4\ud589 \uac00\ub2a5\ud55c \uc778\uc0ac\uc774\ud2b8\ub85c \uc804\ud658\ud569\ub2c8\ub2e4.<\/p>\n

\uc774\uc640 \uac19\uc740 \ud1b5\ud569 \uc811\uadfc \ubc29\uc2dd\uc740 \ube14\ub85d\ubc84\uc2a4\ud130 \uc2e0\uc57d \uc120\uc815 \uacfc\uc815\uc5d0\uc11c\ub3c4 \uadf8 \uac00\uce58\ub97c \uc785\uc99d\ud588\uc73c\uba70, \uc0dd\uba85\uacfc\ud559 \uae30\uc5c5\uc774 CRL\uc5d0 \ub300\uc751\ud558\ub294 \uacfc\uc815\uc5d0\uc11c\ub3c4 \ub3d9\uc77c\ud558\uac8c \uc911\uc694\ud55c \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4. CRL \ub300\uc751\uc740 \ub2e4\uc591\ud55c \ub370\uc774\ud130 \uc18c\uc2a4\uc640 \ubd84\uc11d \uad00\uc810\uc774 \ube60\ub974\uac8c \uacb0\ud569\ub418\uc5b4\uc57c \ud558\ub294 \ub9cc\ud07c, \uc774\ub7ec\ud55c \ud1b5\ud569 \uc778\ud154\ub9ac\uc804\uc2a4\uc758 \ud65c\uc6a9\uc774 \ud544\uc218\uc801\uc785\ub2c8\ub2e4. \uc2e0\ub8b0\ud560 \uc218 \uc788\ub294 \ucd9c\ucc98\uc5d0\uc11c \uc81c\uacf5\ub418\ub294 \ud575\uc2ec \uc815\ubcf4\uc758 \uc2e4\uc2dc\uac04 \uc5c5\ub370\uc774\ud2b8\ub294 \uaddc\uc81c \uacb0\uc815\uc774 \uc7a0\uc7ac \uc2dc\uc7a5\uc5d0 \ubbf8\uce58\ub294 \uc601\ud5a5\uc744 \uc7ac\ud3c9\uac00\ud558\uac70\ub098, \uce58\ub8cc\uc81c\uac00 \ud658\uc790\uc5d0\uac8c \ubbf8\uce58\ub294 \uc601\ud5a5\uc744 \uc774\ud574\ud558\uac70\ub098, CRL \uc774\ud6c4\uc758 \ud5a5\ud6c4 \uc804\ub7b5\uc744 \uc218\ub9bd\ud558\ub294 \ub4f1 \ub2e4\uc591\ud55c \uc0c1\ud669\uc5d0\uc11c \ubbfc\ucca9\ud55c \ub300\uc751\uc744 \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4.<\/p>\n

 <\/p>\n

CRL \uc7ac\uc81c\ucd9c \uc804\ub7b5\uc744 \uac15\ud654\ud558\ub294 \ud074\ub798\ub9ac\ubca0\uc774\ud2b8 \uc194\ub8e8\uc158 <\/strong><\/h3>\n

\ud074\ub798\ub9ac\ubca0\uc774\ud2b8\ub294 R&D\ubd80\ud130 \uc0c1\uc5c5\ud654\uae4c\uc9c0 \uc804 \uacfc\uc815\uc5d0 \uac78\uccd0 \ud65c\uc6a9 \uac00\ub2a5\ud55c 10\uac1c\uc758 \ud1b5\ud569 AI \uae30\ubc18 \ub370\uc774\ud130\uc14b<\/strong>\uc744 \uc81c\uacf5\ud558\uba70, \uc774 \uc911 \uc77c\ubd80\ub294 CRL \ub300\uc751\uc5d0 \ud2b9\ud788 \uc911\uc694\ud55c \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4.:<\/p>\n

    \n
  1. Cortellis Regulatory Intelligence<\/a> (AI\uae30\ubc18 Regulatory Assistant): \uc608: \uaddc\uc81c \uc120\ub840 \ubd84\uc11d, \uaddc\uc81c \uc804\ub7b5 \uc218\ub9bd, FDA\uc758 \uc694\uad6c \uadfc\uac70 \uc218\uc900(evidence bar) \uc774\ud574<\/li>\n
  2. Cortellis Clinical Trials Intelligence<\/a>: \uc608: \uac15\ud654\ub41c \uc548\uc804\uc131 \ubaa8\ub2c8\ud130\ub9c1 \ud504\ub85c\ud1a0\ucf5c \uc124\uacc4, \uc131\uacf5 \uac00\ub2a5\uc131\uc774 \ub192\uc740 \ud658\uc790 \ud558\uc704\uad70 \ub300\uc0c1 \uc784\uc0c1\uc2dc\ud5d8 \uc124\uacc4<\/li>\n
  3. DRG Fusion<\/a> (\ub9ac\uc5bc\uc6d4\ub4dc \ub370\uc774\ud130 \ubd84\uc11d \ud50c\ub7ab\ud3fc): \uc608: \ub9ac\uc5bc\uc6d4\ub4dc \ub370\uc774\ud130\ub97c \ud65c\uc6a9\ud55c \ucd94\uac00 \uc720\ud6a8\uc131 \ubc0f \uc548\uc804\uc131 \uadfc\uac70 \uc0dd\uc131, \uc704\ud5d8\uc774 \ub0ae\uc740 \ud658\uc790\uad70 \uc2dd\ubcc4<\/li>\n
  4. Epidemiology Intelligence<\/a>: \uc608: \uc704\ud5d8\uc774 \ub0ae\uc740 \ud658\uc790 \ud558\uc704\uad70\uc5d0\uc11c\uc758 \uce58\ub8cc \ub300\uc0c1 \ud658\uc790 \uaddc\ubaa8 \uc0b0\uc815, \uc784\uc0c1\uc801 \uc774\uc810\uc774 \uac00\uc7a5 \uba85\ud655\ud55c \ud658\uc790\uad70 \uc815\uc758<\/li>\n
  5. Cortellis Competitive Intelligence<\/a>:\uc608: \uac1c\ubc1c \uae30\uac04\uc774 \uc5f0\uc7a5\ub418\ub294 \ub3d9\uc548 \uacbd\uc7c1 \ud658\uacbd\uc5d0 \ub300\ud55c \uc804\ub7b5\uc801 \uc778\uc2dd \uc720\uc9c0, \uc758\uc0ac\uacb0\uc815\uc774 \ucd9c\uc2dc \uc77c\uc815 \ubc0f \ub9e4\ucd9c \uc804\ub9dd\uc5d0 \ubbf8\uce58\ub294 \uc601\ud5a5\uc744 \uc608\uce21 \ubd84\uc11d\uc744 \ud1b5\ud574 \ud3c9\uac00<\/li>\n
  6. Disease Landscape & Forecast<\/a>: \uc608:\uac1c\ubc1c \uc9c0\uc5f0 \uc0c1\ud669\uc5d0\uc11c\ub3c4 \uacbd\uc7c1 \ud658\uacbd \ubc0f \ud3ec\ud2b8\ud3f4\ub9ac\uc624 \uc804\ub7b5 \uc720\uc9c0<\/li>\n
  7. Access and reimbursement intelligence<\/a>: \uc608: \uac1c\ubc1c \uae30\uac04 \ub3d9\uc548 \ub9c8\ucf13 \uc561\uc138\uc2a4 \uc804\ub7b5\uc744 \uc218\ub9bd\u00b7\uc815\uad50\ud654\ud558\uc5ec \uc2b9\uc778 \uc774\ud6c4 \ube60\ub978 \uc2dc\uc7a5 \uc9c4\uc785 \uc9c0\uc6d0<\/li>\n<\/ol>\n

    \uc774 \uc2dc\ub9ac\uc988\uc758 \ub2e4\uc74c \uae00\uc5d0\uc11c\ub294 \uc774\ub7ec\ud55c AI \uae30\ubc18 \ud074\ub798\ub9ac\ubca0\uc774\ud2b8 \uc194\ub8e8\uc158\uc774 \uaddc\uc81c \uc81c\ucd9c \uacfc\uc815\uc5d0\uc11c \ud3b8\uc775-\uc704\ud5d8 \ud3c9\uac00\ub97c \uc5b4\ub5bb\uac8c \uc9c0\uc6d0\ud558\ub294\uc9c0<\/strong><\/a>\ub97c \ubcf4\ub2e4 \uc790\uc138\ud788 \uc0b4\ud3b4\ubd05\ub2c8\ub2e4.<\/p>\n

    \ub610\ud55c 2026\ub144 \ube14\ub85d\ubc84\uc2a4\ud130 \uc2e0\uc57d\ubcf4\uace0\uc11c(Drugs to Watch 2026)<\/a>\uc5d0 \ub300\ud55c \uc790\uc138\ud55c \ub0b4\uc6a9\uacfc, \ud074\ub798\ub9ac\ubca0\uc774\ud2b8\uac00 AI\ub97c \ud65c\uc6a9\ud574 \uace0\uac1d\uc774 \ub354 \ube60\ub974\uace0 \uc815\ud655\ud55c \uc758\uc0ac\uacb0\uc815\uc744 \ub0b4\ub9b4 \uc218 \uc788\ub3c4\ub85d \uc9c0\uc6d0\ud558\ub294 \ubc29\ubc95<\/a>\ub3c4 \ud568\uaed8 \ud655\uc778\ud558\uc2e4 \uc218 \uc788\uc2b5\ub2c8\ub2e4.
    \n<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

    \uc57d\ubb3c\uc758 \uc2dc\uc7a5 \uc9c4\uc785 \uacbd\ub85c\uac00 \uc608\uc0c1\uce58 \ubabb\ud55c \uaddc\uc81c \uc870\uce58\ub85c \ubcf5\uc7a1\ud574\uc9c8 \uacbd\uc6b0, \uc81c\uc57d\uc0ac\ub294 \uc911\ub300\ud55c \uac08\ub9bc\uae38\uc5d0 \ub193\uc774\uac8c \ub429\ub2c8\ub2e4. \uc2e0\uc18d\ud558\uace0 \ud6a8\uacfc\uc801\uc73c\ub85c \ub300\uc751\ud558\uc9c0 \ubabb\ud558\uba74 \uac1c\ubc1c \uc77c\uc815\uc740 \ubb3c\ub860 \uacbd\uc7c1 \uc6b0\uc704\uae4c\uc9c0 \uc783\uc744 \uc218 \uc788\uae30 \ub54c\ubb38\uc785\ub2c8\ub2e4. \ud074\ub798\ub9ac\ubca0\uc774\ud2b8\uc758 \u20182026\ub144…<\/p>\n","protected":false},"author":141,"featured_media":574158,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_links_to":"","_links_to_type":0,"footnotes":""},"categories":[2452],"tags":[2559,2562,2864,2653,2776,2627,2464,1414,2867,2870,2686],"class_list":["post-579582","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biopharma","tag-biopharma","tag-biotech","tag-clinical-trials","tag-commercialization","tag-fda","tag-market-access-2","tag-pharma","tag-real-world-data","tag-regulatory","tag-safety","tag-u-s"],"acf":[],"lang":"ko","translations":{"ko":579582,"en":574157,"ja":574218},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/579582","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/users\/141"}],"replies":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/comments?post=579582"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/579582\/revisions"}],"predecessor-version":[{"id":579584,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/posts\/579582\/revisions\/579584"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media\/574158"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=579582"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/categories?post=579582"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/tags?post=579582"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}